Angiotensin Receptor Blockers in Clinical Practice – Implications of the ONTARGET Study

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.1, 2012-01, pp. : 10-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Hyperkalemic Risk in Hospitalized Patients Treated with Different Angiotensin Receptor Blockers: A Retrospective Cohort Study Using a Korean Clinical Research Database

By Park Inwhee

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 255-262

Adis International

Access to resources Recommend Favorite

Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction

By Salam Amar M

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 501-507

Informa Healthcare

Access to resources Recommend Favorite

Drug interactions with angiotensin receptor blockers

By Böhler Steffen Pittrow David Bramlage Peter Kirch Wilhelm

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 7-18

Informa Healthcare

Access to resources Recommend Favorite

Vascular benefits of angiotensin receptor blockers

By Voors Adriaan A

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Clinical Experience with the Use of Angiotensin Receptor Blockers in Patients with Cardiovascular, Cerebrovascular and Renal Diseases

Current Clinical Pharmacology, Vol. 1, Iss. 2, 2006-05 ,pp. : 139-146

Bentham Science Publishers

Access to resources Recommend Favorite